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1. Introduction
Viroporins are an increasingly recognized class of small viral membrane proteins (~60-120
amino acids) which oligomerize to produce hydrophilic pores at the membranes of virus-
infected cells [1]. The existence of ‘viroporins’ was proposed more than 30 years ago after
observing enhanced membrane permeability in infected cells [2]. These proteins form
oligomers of defined size, and can act as proton or ion channels, and in general enhancing
membrane permeability in the host [3]. Even though viroporins are not essential for the rep‐
lication of viruses, their absence results in attenuated or weakened viruses or changes in
tropism (organ localization) and therefore diminished pathological effects [4, 5].
In addition to having one – sometimes two – α-helical transmembrane (TM) domain(s), viro‐
porins usually contain additional extramembrane regions that are able to make contacts
with viral or host proteins. Indeed, the network of interactions of viroporins with other viral
or cellular proteins is key to understand the regulation of viral protein trafficking through
the vesicle system, viral morphogenesis and pathogenicity.
In general, viroporins participate in the entry or release of viral particles into or out of cells,
and membrane permeabilization may be a desirable functionality for the virus. Indeed, sev‐
eral viral proteins that are not viroporins are known to affect membrane permeabilization,
e.g., A38L protein of vaccinia virus, a 33-kDa glycoprotein that allows Ca2+ influx and indu‐
ces necrosis in infected cells [6]. In viruses that lack typical viroporins, their function may be
replaced by such pore-forming glycoproteins. For example, HIV-2 lacks typical viroporins,
and ROD10 Env is an envelope glycoprotein that enhances viral particle release. In HIV-1,
this function is attributed to the viroporin Vpu [7].
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An important point that needs to be established, in view of the observed channel activi‐
ty of viroporins, is whether the channels they form are selective, with a controlled gating
mechanism, or whether permeabilization is non selective, like in some antimicrobial pep‐
tides  [8].  Viroporins  have  also  been  found  to  modulate  endogenous  cellular  channels
[9-12] and this activity may also have an important regulatory role during the life cycle
of the virus.
Viroporins can be found in all kinds of viruses, RNA, DNA, enveloped and non-enveloped.
Examples of viroporins are picornavirus 2B [13], alphavirus 6K [14-16], HIV-1 Vpu [17, 18],
influenza virus A M2, (also called AM2) [19], RSV SH protein [20], p10 protein of avian reo‐
virus [21], Human hepatitis C virus (HCV) and bovine viral diarrhea virus (BVDV) p7 [22,
23], Paramecium bursaria chlorella virus (PBCV-1) Kcv [24], and coronavirus envelope pro‐
teins, e.g., SARS-CoV E [25, 26]. Recent reviews [27, 28] provide more examples and possible
functional roles.
The most extensively studied viroporin to date is probably the M2 protein from influen‐
za  A virus  (AM2).  AM2 protein  is  97-residue  long,  with  one  transmembrane  (TM)  do‐
main and a C-terminal cytoplasmic amphiphilic helix. AM2 forms homotetramers and is
located in the viral  envelope,  where it  enables  protons from the endosome to enter  the
viral particle (virion). This lowers the pH inside the viral particle, causing dissociation of
the viral matrix protein M1 from the ribonucleoprotein RNP, uncoating of the virus and
exposure of  the content  to the cytoplasm of  the host  cell.  AM2 also delays acidification
of the late Golgi in some strains [29, 30].
The proton channel activity of AM2 can be inhibited by antiviral drugs amantadine and ri‐
mantadine, which block the virus from taking over the host cell. Two different high-resolu‐
tion structures of truncated forms of AM2 have been reported: the structure of a mutated
form of its TM region (residues 22-46) [31], and a slightly longer form (residues 18-60) con‐
taining the TM region and a segment of the C-terminal domain [32, 33]. These studies sug‐
gest that the known AM2 adamantane inhibitors, amantadine and rimantadine, act by either
blocking the pore [31, 34] or by an allosteric mechanism [32]. New AM2 inhibitors have been
reported [35], but their effectiveness against adamantane-resistant viruses remains to be es‐
tablished. The use of these drugs presents a classical example of targeting viral channels to
treat viral infection infection [31, 32, 36].
The case of AM2 protein in influenza A represents a link between viroporin activity and
structure  to  viral  pathogenesis.  Unfortunately,  for  many  viroporins  even  rudimentary
structural  models are lacking due to high hydrophobicity,  conformational flexibility and
tendency to aggregate. For some viroporins however, increasing degrees of structural in‐
formation can be obtained due to availability of high quality purified protein. Examples
of these are the viroporins present in coronaviruses (CoV) and in the respiratory syncy‐
tial virus (RSV), envelope (E) protein and the small hydrophobic (SH) protein, respective‐
ly. Both types of virus infect the upper and lower respiratory tract of humans, and their
viroporins are the subject of this chapter.
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2. Envelope (E) and Small Hydrophobic (SH) proteins in respiratory
viruses
2.1. SH protein in hRSV
Medical  impact  of  the human respiratory syncytial  virus (hRSV) infection.  hRSV is  a
member  of  the  Paramyxoviridae  family,  and  is  the  leading  cause  of  bronchiolitis  and
pneumonia  in  infants  and  the  elderly  worldwide  [37].  hRSV  infection  is  the  most  fre‐
quent cause of  hospitalization of  infants and young children in industrialized countries.
In the USA alone, around 100,000 infants with hRSV infection are hospitalized annually.
hRSV also is a significant problem in the elderly, patients with cardiopulmonary diseases
and in immunocompromised individuals. hRSV accounts for approximately 10,000 deaths
per year in the group of >64 years of age in the US. Globally,  hRSV infection results in
64  million  cases  and  160,000  deaths  every  year  (http://www.who.int/vaccine_research/
diseases/ari/en/index2.html).
There is currently no effective vaccine available to prevent hRSV infection. Development of
vaccines has been complicated by the fact that host immune responses appear to play a sig‐
nificant role in the pathogenesis of the disease [38]. Naturally acquired immunity to hRSV is
neither complete nor durable, and recurrent infections occur frequently during the first
three years of life. Palivizumab, a humanized monoclonal antibody directed against hRSV
surface fusion F protein (Synagis, by MedImmune), is moderately effective but very expen‐
sive. It is currently available as prophylactic drug for infants at high risk. Cost of prevention
limits its use in many parts of the world. The only licensed drug for use in infected people is
ribavirin, but its efficacy is limited. Antibodies against both F (fusion) and G (attachment)
proteins have been found in the serum of hRSV infected patients, but only provide tempora‐
ry protection. Therefore, low immunoprotection and lack of suitable antivirals leads to‐
wards the search and characterization of new drug targets for the effective treatments of
hRSV infection. A possible suitable target is the SH protein as will be elaborated below.
The viral particle formation in RSV. Based on the reactive patterns to monoclonal antibod‐
ies, there are two hRSV strains that co-circulate in human populations, subtypes A and B.
The hRSV genome comprises a nonsegmented negative-stranded RNA of ~15 kb that tran‐
scribes 11 proteins, including the three membrane proteins fusion (F), attachment (G), and
small hydrophobic (SH) [39, 40]. The F protein is sufficient for mediating viral entry into
cells in vitro, and the G protein plays a role in viral attachment [41, 42]. In contrast, the pre‐
cise role of SH protein is still unclear.
hRSV also contains six internal structural proteins: the matrix (M) protein, which provides
structure for the virus particle, nucleoprotein (N), phosphoprotein (P) and large (L) poly‐
merase protein form the ribonucleoprotein (RNP) complex, which encapsidates the RSV ge‐
nome and functions as the RNA-dependent RNA polymerase. Lastly, two isoforms of
matrix protein 2 (M2-1 and M2-2) are accessory proteins that control transcription and repli‐
cation [43]. Viral proteins traffic to the apical surface of polarized epithelial cells, where they




assemble into virus filaments at the plasma membrane [44], although the mechanisms that
drive assembly into filaments and budding are not well understood.
Generation of nascent hRSV genomic RNA appears to occur in discrete cytoplasmic inclu‐
sion bodies that contain the hRSV N, P, L, M2-1 and M2-2 proteins but not the F, G, or SH
proteins [45]. It is suspected that the RNP complexes form in the inclusions and then traffic
to the apical membrane, where they meet with the surface glycoproteins F, G, and SH arriv‐
ing from the Golgi apparatus through the secretory pathway [46]. hRSV proteins and viral
RNA assemble into virus filaments at the cell surface. These filaments are thought to con‐
tribute to cell-cell spread of the virus and morphologically resemble the filamentous form of
virions seen in electron microscopy (EM) studies of virus produced in polarized cells [47].
The small hydrophobic (SH) protein. The SH protein is 65 or 64 amino acids long, in sub‐
type A or B, respectively. SH protein has a single membrane-spanning hydrophobic region
[48], and a C-terminal extramembrane tail, oriented extracellularly/lumenally [48]. The se‐
quence of SH protein is highly conserved, especially at the TM domain [49, 50]. hRSV that
lacks SH protein, hRSVΔSH, is still viable, and still forms syncytia [51-53]. However,
hRSVΔSH was attenuated in in vivo mouse and chimpanzee models [4, 5], which indicates
that SH protein is important for hRSV pathogenesis. SH protein has been suggested to play
an ancillary role in virus-mediated cell fusion [54, 55]. Also, the presence of SH protein has
been shown to reduce cytopathic effect (CPE) and apoptosis in L929 and A549 (lung epithe‐
lial cell line) infected cells, at least in part by inhibiting tumor necrosis factor α (TNF-α) pro‐
duction [56], similarly to parainfluenza virus 5 (PIV5).
Interaction of SH protein with viral and host proteins. Extensive protein-protein interac‐
tions have been observed between the three membrane proteins on the hRSV envelope, F, G,
and SH [51, 57, 58] and these interactions have an effect on fusion activity of hRSV on the
host [51, 54]. In cells transiently expressing hRSV membrane proteins, the presence of G and
SH proteins enhanced fusion activity mediated by F protein [54, 55]. Thus, SH protein has
been suggested to play an ancillary role in virus-mediated cell fusion. However, using virus-
infected cells the presence of G protein alone enhanced F-mediated fusion activity [51],
whereas SH protein in the absence of G protein inhibited it, suggesting a possible interaction
between SH and G [51]. Viruses where the SH protein gene was deleted grew better in
HEp-2 cells [55], leading to the suggestion of a negative regulatory effect of SH protein on
virus-induced membrane fusion, although direct interaction between SH protein and fusion-
responsible F protein has not been observed [58], whereas complexes F-G and G-SH have
been detected on the surface of infected cells using immunoprecipitation [58] and heparin
agarose affinity chromatography [57]. These three proteins not only form hetero-oligomers,
but also homo-oligomers: F forms trimers [59], G forms tetramers [60], and SH forms pen‐
tamers [48, 61, 62]. Thus, a complicated regulatory network of interactions may exist which
probably includes both homo- and hetero-oligomeric forms.
In addition to interactions with viral proteins, the fact that SH proteins of hRSV and par‐
ainfluenza virus 5 (PIV5) are necessary for the inhibition of  tumor necrosis factor alpha
(TNF-α)-induced  apoptosis  [56,  63]  also  suggests  a  possible  interaction  with  host  pro‐
teins,  although this  has not  been confirmed experimentally.  However,  in another study,
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deletion of  SH protein gene from RSV did not  result  in  increased apoptosis  in  infected
H441 cells [11].
Localization and post-translational modifications of SH protein during viral infection. In
infected cells, some SH protein is found in plasma membrane and cytoplasm, but most of
the SH protein accumulates at the membranes of the Golgi complex and only very low
amounts are found in the viral envelope [64]. Several forms of the SH protein, glycosylated
and non-glycosylated, are present during infection [65], but the non-glycosylated form ap‐
pears to be the most abundant [66]. SH protein is also modified by tyrosine phosphorylation
[61], and increased accumulation of SH in the Golgi complex was observed in the presence
of a kinase inhibitor. Thus, SH protein is modified by a MAPK p38-dependent tyrosine kin‐
ase activity and this modification influences its cellular distribution. Although SH contains
one cysteine residue, no palmitoylation has been detected in SH protein in conditions where
F and G were palmitoylated [48].
Structural determination of SH protein. An important step towards the understanding of
viroporin function at the molecular level is the availability of these proteins in a highly pure
form. This has been so far difficult due to their high hydrophobicity, toxicity to expression
hosts, and tendency to aggregate. However, recently we have been able to obtain the full
length SH protein [67] that allows structural and biophysical studies (Fig. 1A).
SH protein after  cross-linking has been shown to form multiple oligomers of  increasing
size in SDS [66, 68]. Later, we showed that the TM domain of SH protein forms only ho‐
mopentamers  in  perfluoro-octanoic  acid  (PFO)  gels  [69].  Reports  using  purified  full-
length SH protein have confirmed the pentameric nature of the oligomer formed by this
protein.  For  example,  a  bundle  formation of  a  tagged SH protein  construct  was  visual‐
ized  under  electron  microscopy  and  was  interpreted  as  a  pentameric  or  a  hexameric
structure [70]. Using a purified tag-free SH protein, we have unequivocally demonstrated
the homo-pentameric nature of  these oligomers in a variety of  detergents using analyti‐
cal  ultracentrifugation  and electrophoresis  (Fig.  1)  [71].  Indeed,  in  the  presence  of  PFO
(Fig.  1B)  and  a  variety  of  other  detergents  under  Blue-native  gel  electrophoresis  (Fig.
1C),  the  full-length  SH protein  migrates  as  a  single  band with  a  molecular  weight  ~40
kDa, consistent with a pentameric oligomer. The pentameric form of SH has been further
confirmed by analytical ultracentrifugation sedimentation equilibrium in detergents DPC,
C14SB  and  C8E5  micelles.  In  these  detergents,  the  species  distribution  profiles  show  a
best fit to a monomer-pentamer self-association model (Fig. 1 D-E).
Secondary structure of SH protein.  The SH protein is predicted to have an α-helical re‐
gion  spanning residues  16-46,  which  includes  its  predicted  TM region (residues  ~20-40,
Fig.  1A).  Fourier  Transform infrared (FTIR) data for  the full-length SH protein reconsti‐
tuted in model lipid bilayers shows the presence of ~60% α-helical structure, whereas the
rest  is  β-structure  [71].  The  availability  of  purified,  isotopically  labeled  protein  allowed
us to obtain a model for this pentameric oligomer where SH protein was reconstituted in
DPC micelles  using NMR (Fig.  2).  The model  shows the lumen of  the hypothetic  chan‐
nel, sufficient for the passage of ions.




Figure 1. Sequence and oligomerization of SH protein from hRSV subtype A. (A) Amino acid sequence of full-length
SH protein, with three additional N-terminal residues, SNA, as a result of tobacco etch virus (TEV) protease cleavage to re‐
move the expression tag [71]; (B) Gel electrophoresis analysis of SH protein in PFO shows a band consistent with pentamers
(arrow); (C) Blue-native gel electrophoresis of wild type SH protein (WT) and double mutant H22F/H51F (FF) presolubi‐
lized in a variety of detergents show one band migrating consistent with pentamers (arrows); (D) Analytical ultracentrifu‐
gation sedimentation equilibrium data for 50 μM SH (WT) protein collected at three different speeds: 16,000 (blue),
19,500 (green), and 24,000 (red) rpm. Sedimentation profile was globally best-fitted to a monomer-pentamer equilibrium
model. The graph shows both data points (black filled circles) and fitted function (in color). Lower panels represent fit resid‐
uals; (E) SH (WT) oligomeric species distribution in C14SB, C8E5 and DPC detergents, where the thick bar on the curve rep‐
resents the range of protein:detergent molar ratios used in the AUC experiment. The dotted line indicates the protein:DPC
molar ratio (1:200) used in the NMR experiments [71] and its corresponding pentamer fraction (~90%). C14SB, DPC and
C8E5 detergent concentrations were 5, 15 and 33 mM, respectively.
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Figure 2. NMR-based pentameric model of RSV SH protein in detergent DPC micelles [71]. (A) Side view; (B) N-
terminal (cytoplasmic) view; (C) C-terminal (extracellular or lumenal) view; (D) Electrostatic surface of the assembly
showing the mostly hydrophobic central lumen. The SH protein assembly spans the entire bilayer with an overall
length of about 45 Å.
Ion channel activity of SH protein. The presence of SH protein at the plasma membrane of
HEK293 transfected cells allowed the study of SH protein channel activity [71], which was
reported to be pH sensitive. Mutants where both histidines, H22 and H51 (Fig. 1A), were
changed to phenylalanine (FF mutant, Fig. 1C), were found to be channel inactive. In a Blue-
native gel electrophoresis, this FF mutant showed similar electrophoretic mobility (Fig. 1C)
and similar plasma membrane localization to the wild type [71], which suggests that the ob‐
served channel activity is not mediated by direct or indirect interaction of SH protein with
host-endogenous channels.
One of the two histidines, His22, was suggested to face the lumen of the pentameric oligom‐
er using site-specific infrared dichroism of the isotopically labeled TM domain reconstituted
in model lipid bilayers [69]. In the NMR based model of the full length protein (Fig. 2), al‐
though His22 adopts a lumenal orientation, the second histidine, His51, appears in an extra‐
membrane location, at the tip of the C-terminal extended loop (Fig. 2A), which is difficult to
reconcile with an activation role based on His protonation. Thus, it is possible that the struc‐
ture of this C-terminal domain in detergent micelles, used for the NMR experiment, does
not represent accurately the structure of SH protein in lipid bilayers, where we obtained the
patch clamp data. Nevertheless, the pH-activated channel activity observed, and the histi‐
dine-less inactive mutant strongly suggests that protonation of histidines may be involved
in channel activity. Indeed, the presence of a lumenal histidine sidechain is reminiscent of
the one found in the TM domain of the influenza A AM2 proton channel, which is also acti‐
vated at low pH via histidine protonation [33].
Despite  the similarities  between AM2 and SH protein,  we have been unable  to  observe
strong proton channel activity of SH protein in vitro (unpublished observations). In addi‐
tion, the different life cycle of hRSV and influenza virus A does not provide a rationale
for this hypothetic proton channel activity. Equally, no obvious rationale can be assigned
to  pH mediated  activation.  The  use  of  specific  channel  inhibitors  for  SH protein  could
contribute to clarify the precise role of channel activity in this protein, disentangled from
other effects.




2.2. E protein in coronaviruses
Medical impact of coronaviruses. Coronaviruses (family Coronaviridae, genus Coronavirus
[72]) are enveloped viruses that cause common cold in humans and a variety of lethal dis‐
eases in birds and mammals [73]. The species in the genus Coronavirus have been organized
into 3 groups with genetic and antigenic criteria [74]: α-coronaviruses include the porcine
Transmissible gastroenteritis virus (TGEV) and Human coronaviruses 229E (HCoV-229E) or
NL63 (HCoV-NL63). β-coronaviruses include Murine hepatitis virus (MHV) and Human coro‐
navirus OC43 (HCoV-OC43). γ-coronaviruses include the avian Infectious bronchitis virus
(IBV) and the Turkey coronavirus (TCoV). The virus responsible for the severe acute respira‐
tory syndrome (SARS-CoV), a respiratory disease in humans, is close to the β-coronaviruses,
formerly group 2 [75].
SARS produced a near pandemic in 2003, with 8,096 infected cases and 774 deaths world‐
wide (fatality rate of 9.6%). Mortality was 6% for those aged 25-44, 15 % for the 45-64 group
and >50% for those over 65 (http://www.who.int/csr/sarsarchive/2003_05_07a/en/). For compari‐
son, the case fatality rate for influenza A is usually around 0.6% (primarily among the elder‐
ly) and 33% in locally severe epidemics of new strains. SARS-CoV was enzootic in an
unknown animal or bird species, probably a bat [76], before suddenly emerging as a virulent
virus in humans. A similar crossing of the animal-human species barrier is thought to have
occurred between the bovine coronavirus (BCoV) and human coronavirus OC43 (HCoV-
OC43) more than 100 years ago [77]. Such interspecies jumps, from animal hosts to humans,
are likely to reoccur.
Protective efficacy of candidate vaccines against coronaviruses in humans has been mainly
studied in animals so far, and only few vaccines have entered Phase 1 human trials [78]. Rib‐
avirin [79], interferons [80], unconventional agents [81-83] and non-steroidal anti-inflamma‐
tory agents [84] have shown activity against SARS-CoV and HCoV-229E, but there is no
data from animal studies or clinical trials [85]. Studies of antiviral therapy against coronavi‐
ruses other than SARS-CoV have been scarce; in vitro data show that several chemicals may
have inhibitory activities on HCoV-NL63 and HCoV-229E [86, 87].
In addition to the genes involved in viral RNA replication and transcription, other essential
genes in coronaviruses encode the common viral structural proteins, S (spike), E (envelope),
M (membrane) and N (nucleocapsid). Of these, S, E, and M are incorporated into the virion
lipidic envelope, and S protein is involved in fusion with host membranes during entry into
cells. The M protein is the most abundant constituent of coronaviruses and gives the virion
envelopes their shape; the E protein is only a minor constituent of the virion but is abun‐
dantly expressed inside the infected cell [88-90].
The E protein in SARS-CoV is the shortest, with only 76 amino acids, whereas that of IBV E
is one of the longest (109 amino acids). E protein sequences are extremely divergent in their
sequence, but the same general architecture is found in all of them: a short hydrophilic N-
terminus (8–12 residues), an N-terminal TM domain (21–29 residues) followed by a cluster
of 2-3 cysteines which are likely to be palmitoylated, and finally a less hydrophobic C-termi‐
nal tail (39–76 residues). Prediction of TM domains of representatives of coronavirus E pro‐
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teins from several species using a hidden Markov model (e.g., http://phobius.sbc.su.se/) [91]
shows that they have at least one α-helical TM domain. In some cases a second TM domain
is also predicted, e.g., in IBV E and MHV E (Fig 3). However, in none of these coronavirus E
proteins this second putative TM has a predicted α-helical conformation. Instead, a β-coil-β
motif appears to predominate in that part of the sequence, with a totally conserved Pro resi‐
due in a central position (‘P’ in Fig. 3).
Figure 3. Secondary structure and TM prediction of E proteins of coronaviruses. E proteins from four representa‐
tives of coronavirus are presented: TGEV, MHV, SARS-CoV and IBV E proteins. Regions predicted to be α-helical, β-
sheet, or random coil are marked in blue, red, and yellow, respectively. Red bars show the probability of a region being
a TM domain. The location of the conserved Pro residue in each protein is indicated by a ‘P’.
Topology of E proteins. The topology of coronavirus envelope proteins is an issue still un‐
der debate. Experimental determination of E protein orientation in infected cells [88, 92, 93]
has shown that in TGEV E, the N-terminus is exposed to the cytoplasm, with the C-terminus
facing the Golgi lumen (NcytoCexo). In MHV E, both N and C-terminal ends were found to
face the cytoplasm (NcytoCcyto). For SARS-CoV E, an NcytoCcyto topology, similar to MHV E,
was reported in transfected cells [94], consistent with two TM domains (NcytoCcyto), although
a small fraction of the population (~10%) was found to be glycosylated at residue N66. As
glycosylation must have occurred in the Golgi lumen, the authors suggested the existence of




a minor fraction of E protein in an NcytoCexo topology. However, a study in infected cells de‐
tected the C terminus oriented cytoplasmically and the N-terminus lumenally [95], consis‐
tent with a single TM domain. Lastly, in IBV E, the C-terminus was found exposed to the
cytoplasm, but not the N-terminus, suggesting a topology NexoCcyto, with the N-terminus fac‐
ing the lumen of the Golgi [96].
The results  of  these experiments  should be interpreted with caution,  especially compar‐
ing data from transfected cells and infected cells. Equally, the possible lack of accessibili‐
ty to antibodies of parts of the protein plays a part. Indeed, as discussed elsewhere [97],
in the case of IBV E, if the entire N-terminal region of IBV E protein was buried within
the intracellular membrane,  it  would have remained inaccessible to the antibodies used.
Several  coexisting  forms  may exist  for  E  proteins,  which  would  have  different  roles  in
the life cycle of the virus.
The factors that would favour one topology over another are unknown, but one possible
candidate is palmitoylation. Indeed, E proteins of SARS [26], IBV [98] and MHV [99] are pal‐
mitoylated at one or more cysteines. This modification is likely to have structural and func‐
tional consequences, because removal of the cysteines in MHV E resulted in deformed
viruses [100, 101]. Experimental determination of the topology of these E protein homologs
– with or without palmitoylation – in model membranes or membrane-like detergents is crit‐
ical to understand the function of the envelope protein in coronavirus biology. Unfortunate‐
ly, these detailed structural studies are still not available.
The importance of the correct topology in E proteins may be highlighted by a recent study
[102] that showed that E protein in MHV could be replaced by some heterologous E pro‐
teins. The MHV virus became viable when the replacement was from groups 2, i.e., β-coro‐
naviruses (SARS-CoV E) and 3, i.e., γ-coronaviruses (IBV E), but not when TGEV E (group 1,
or α-coronaviruses) was used. This discrimination may have to do with topology considera‐
tions, because the contribution of E proteins to the formation of viral particles in coronavi‐
ruses could be provided by a broad range of sequences, and not by specific interactions.
Localization of E protein during viral infection. E protein can be found between the ER
and Golgi compartments inside the cell [103-105]. However, only a small amount ends up in
the virion [88-90], suggesting that its main role is inside the cell [95]. In transfected HeLa
cells, SARS-CoV E protein is targeted to the Golgi complex, and this localization has been
attributed, at least in part, to the β-hairpin motif in its C-terminus [106] (see Fig. 3). In infect‐
ed Vero E6 cells, SARS-CoV E protein accumulates in the ER-Golgi intermediate compart‐
ment (ERGIC) [95]; the latter study could not detect any SARS-CoV E protein in the plasma
membrane.
Effect of coronavirus E gene deletion. While the absence of S and M protein are clearly del‐
eterious to the virus because of their abundance and key role in envelope formation, the E
protein is not essential for in vitro or in vivo coronavirus replication. However, the absence of
E protein results in an attenuated virus, as shown for SARS-CoV [107] and other coronavi‐
ruses (see below). Recently, it has been shown that SARS viruses lacking gene E, in addition
to being attenuated, did not grow in the central nervous system, in contrast to the wild type
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virus [108]. This suggests a role of the SARS-CoV E gene as a virulence factor influencing
tissue tropism and pathogenicity. Recently, SARS-CoV lacking E gene has been suggested as
vaccine candidate [109]. Studies using the E deleted SARS-CoV E have shown that E protein
affects stress and inflammation responses [110], which probably contribute to the attenua‐
tion of the virus observed in the absence of this protein [107].
In other coronaviruses, it has been found that E protein is involved in viral morphogene‐
sis,  e.g.,  co-expression  of  M  and  E  is  sufficient  for  formation  and  release  of  virus-like
particles  (VLP) in the host  cell  [93,  111-115].  Also,  mutations in the extramembrane do‐
main of  E protein were shown to impair  viral  assembly and maturation in MHV [116],
probably due to a defective interaction with M protein.  In TGEV, the absence of E pro‐
tein resulted in a blockade of virus trafficking in the secretory pathway, and the preven‐
tion of virus maturation [117, 118].
Interaction partners of E proteins. The interaction of E protein with M in IBV has already
been reported by two different labs [96, 119] and involves at least the C-terminal tail of these
two proteins, which therefore should be on the same side of the lipid bilayer. Additionally,
the extramembrane cytoplasmic tail of SARS-CoV E has also been reported to bind Bcl-XL
[120] and the N-terminal domain of non-structural protein 3 (nsp3) [121]. Similar studies
have shown that SARS-CoV E via its four last C-terminal amino-acids, interacts with the
host protein, PALS1, a tight junction-associated protein. Intercellular tight junctions are a
physical barrier that protects underlying tissues from pathogen invasions. In SARS-CoV–in‐
fected Vero E6 cells, PALS1 redistributes to the ERGIC/Golgi region, where E accumulates.
Hijacking PALS1 by SARS-CoV E may play a determinant role in the disruption of the lung
epithelium in SARS patients [122]. SARS-CoV E has also been found to interact with Na+/K+
ATPase α-1 subunit and stomatin [95].
Channel activity in coronavirus E proteins. Enhanced permeability has been observed in
bacterial and mammalian cells expressing MHV E [123] or SARS-CoV E [26]. In addition, E
proteins of SARS, human coronavirus 229E, MHV, and IBV, have shown in vitro ion channel
activity in planar lipid bilayers [124, 125], which in some cases was inhibited by the drug
hexamethylene amiloride (HMA) [125]. In a patch clamp study, channel activity was ob‐
served in cells transfected with SARS-CoV E [25], although another study could not detect
SARS-CoV E protein in the plasma membrane of transfected or infected cells [95]. Neverthe‐
less, channel activity has been shown in black lipid membranes for purified synthetic TM
domains and full length SARS-CoV [67, 126, 127], and inactivating mutations located in the
TM domain, N15A and V25F [126], have been confirmed recently in a separate study [128].
In the latter, a significant contribution of lipid composition was observed, and a protein-lip‐
id complex forming pore was proposed. These mutants may help elucidate the contribution
of channel activity to SARS-CoV E protein function.
Structural determination of E protein. At present, detailed structures of coronavirus enve‐
lope proteins are lacking. This is due difficulties in both expression and purification, and to
their high tendency to aggregate which makes crystallization and NMR studies extremely
challenging. Recently, we have successfully utilized a modified β-barrel fusion protein con‐
struct to express and subsequently purify full-length SARS-CoV E and IBV E proteins [67].




We showed that both full length proteins form homopentamers, confirming previous results
obtained only with the synthetic TM domain [25].
Previous  reports  have  studied  the  oligomerization  of  coronavirus  E  proteins.  However,
results were not conclusive, partly because these experiments were performed in SDS, a
harsh  detergent  that  leads  to  monomers  or  to  non-specific  aggregates.  For  example,
SARS-CoV E oligomerization has been studied in Western Blots after SDS-PAGE and la‐
beling with polyclonal antibodies [99],  antibodies against a hemagglutinin-derived C-ter‐
minal  tag  [100],  or  using  non  purified  or  truncated  synthetic  E  proteins  [124,  125].  In
the  latter  approach,  a  predominanly  monomeric  form  was  observed  in  SDS.  In  our
hands,  synthetic  SARS-CoV  E  also  produced  in  SDS  mostly  monomers,  and  a  minor
fraction  of  dimers  (unpublished observations),  but  several  oligomers  were  observed for
the recombinant form (Fig. 4,  lane WT). The differences between synthetic and recombi‐
nant E protein may be due to unwanted side reactions that take place during synthesis.
Addition  of  DTT  (Fig.  4B)  produces  bands  compatible  with  monomers  and  trimers,
whereas  cysteine-less  mutants  only  produced  monomers.  Thus,  the  three  cysteines  in
SARS-CoV E  seem to  participate  in  some inter-monomeric  contacts.  Indeed,  sedimenta‐
tion  data  for  SARS-CoV  E  could  only  be  fitted  after  addition  of  reductant  [67]  in  the
case  of  SARS-CoV  E.  Differences  between  absence  and  presence  of  reductant  were  ob‐
served  even  when  only  one  cysteine  was  available  (Fig.  4B),  therefore  these  disulfide
bonds  may  not  be  specific.  Changes  in  hydrophobicity  and  local  secondary  structure
seem to play a major role in the results  observed.  Further,  disulfide bonds are not nec‐
essary to  form pentamers;  sedimentation equilibrium of  full-length SARS-CoV E or  IBV
E in C14SB detergent and in the presence of reducing agent produced best fit to a mon‐
omer-pentamer  equilibrium  model  [67],  similar  to  what  has  been  observed  for  the  TM
region alone [127].
The likely orientation of these cysteine residues relative the pentameric bundle can be deter‐
mined on the basis of the available structure formed by synthetic TM8-38 [25]. That structure
did not include any of the three cysteines of SARS-CoV E, but if the structural model is pro‐
longed by two turns (Fig. 5), the three cysteines are seen oriented either towards the lumen
of the channel or inter-helically.
The juxtamembrane cysteines in coronavirus envelope proteins are well conserved, and
have been found to be crucial in the coronavirus cycle. For example, in MHV E, removal of
the cysteines resulted in deformed viruses [99-101]. Using the full length infectious clone
[99], double- and triple-mutants to alanine produced smaller plaques and decreased virus
yields. Single-substitution mutants, in contrast, did not produce anomalous growth, where‐
as replacement of all three cysteines resulted in crippled virus with significantly reduced
yields. In these reports, these effects were attributed to the absence of palmitoylation sites,
which may direct E proteins towards lipid rafts [129]. E proteins of SARS [26], IBV [98] and
MHV [99] have been shown to be palmitoylated at one or more cysteines. It is possible that
an additional role of palmitoylation is to drag the C-terminal tail of E proteins towards the
membrane and trigger a conformational change.
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Figure 4. SDS-PAGE electrophoresis of SARS-CoV E and IBV E. (A) SARS-CoV E wild type (WT) and cysteine mutants
in the absence of DTT in gel 4-12 % Nu-PAGE in MES/SDS buffer; (B) same as A in presence of DTT. The lane contain‐
ing the molecular weight markers (MW) is indicated. The oligomeric size is indicated by black circles (●); (C) Effect of
three reductants (DTT, TCEP and β-mercaptoethanol (β-ME) on the electrophoretic mobility SARS-CoV E WT in 15%
SDS PAGE gel.




Figure 5. Cysteine location in the pentameric arrangement of the TM domain of SARS-CoV E. The scheme is ar‐
ranged according to previous published models [25, 130] after prolonging the helices 2 turns at the C-terminal end,
and shows the position of the three cysteines in SARS-CoV E, C40, C43 and C44; A and B, views from the N-terminus of
the pentamer, with C40 (A) and C43 and C44 (B); C, Side view, showing only two helices for clarity, and possible inter‐
helical disulfide bonds C43-C40 and C44-C40.
Dissection of the domains of SARS-CoV E. The four representatives of CoV E proteins
have a predicted α-helical TM domain (Fig. 6a) and a C-terminal region predicted to have β-
structure. Synthetic peptide 36-76 encompasses the C-terminal extramembrane domain and
was analyzed in the presence of DMPC lipid membranes using FTIR. This peptide presented
limited solubility both in water and in organic solvents. The amide I spectrum of this pep‐
tide (Fig. 6b) shows bands assigned to antiparallel β-sheet, because of the splitting of the
amide I band caused by strong inter- and intra-strand transition dipole coupling (TDC)
[131-133], resulting in a weak band at high frequency (1675–1690 cm-1) and a strong band at
lower frequency (1625–1640 cm-1). The band at 1666 cm-1 can be assigned to disordered
structure [134, 135]. The amide A frequency was blue-shifted from that observed for the TM
domain alone [130] (3,305 cm-1) or full length SARS-CoV E (3294 cm-1, not shown) to 3281
cm-1, again consistent with the presence of β-structure. The intensity of the amide II band
decreased upon exposure to D2O (dotted line, Fig. 6b) by about 30 ± 5%, i.e., ~28 residues are
resistant to exchange in this peptide. The fast-exchanging fraction is likely due to the region
predicted to have random coil conformation. Thus, the 36-76 fragment has an intrinsic ten‐
dency to fold as β-sheet, and presents both β-structure and random coil, in agreement with
the secondary structure prediction (Fig. 6a). In fact, the spectrum resulting from the addition
of TM α-helix (8-38) [130] and C-terminal tail (36-76), shown in Fig. 6b, is very similar to the
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spectrum obtained for full length SARS-CoV E (Fig. 6e, dotted line) reconstituted in the
same conditions.
Figure 6. Secondary structure prediction of coronavirus envelope proteins and correspondence with results obtained
for synthetic peptides of SARS-CoV E. (a) Sequences corresponding to E proteins representative of coronavirus groups
1 (TGEV E), 2 (MHV E), 3 (IBV E) and SARS CoV E, and their predicted secondary structure (consensus)[136]. The posi‐
tion of the conserved proline is indicated with a black dot; (b-d) amide I and II bands of the synthetic SARS-CoV E pep‐
tides indicated when incorporated in DMPC bilayers in H2O (solid) or after D2O (dash) hydration. The position of amide
II band is indicated by a star; (e) ATR-FTIR spectra corresponding to SARS-CoV E (solid line), and IBV E (broken line)
reconstituted in DMPC bilayers, in the lipid ester region (1740 cm-1) and amide I region (C=O stretching, 1650 cm-1).
The dotted line resulted from the addition of the spectra corresponding to the TM [130] and fragment 36-76 (panel
b); (f) X-ray diffraction pattern for peptides (36-76) or (46-60) after drying from acetonitrile. The inter-sheet spacing is
10.8 Å (inner ring) whereas the hydrogen bond spacing is represented by the outer ring at 4.8 Å, characteristic of amy‐
loid fibrils. Due to poor alignment, the reflection at distance 4.8 Å appeared as a ring; (g) schematic model of full
length SARS-CoV E build using prediction tools and experimental data obtained using infrared spectroscopy.
Similar experiments with fragments 46-60 and 59-76 (Fig. 6, c-d) showed that 46-60 forms β-
sheets resistant to H/D exchange. Indeed, this latter peptide showed limited solubility, simi‐
lar to the ‘parent’ peptide 36-76. Further, its amide I spectrum in DMPC displayed the




features of antiparallel β-sheet, with bands at 1635 cm-1 and 1685 cm-1 (Fig. 6c) and showed
no H/D exchange in the amide II region (Fig. 6c, star). In contrast, fragment 61-76 is predict‐
ed to form random coil (Fig. 6a), and should show complete H/D exchange. Indeed, the hy‐
drophilic fragment 59–76 dissolved readily in water (>5 mg/ml), produced an amide I
spectrum in DMPC consistent with random structure (Fig. 6d), with a broad amide I band at
1645 cm-1, and showed complete H/D exchange at the amide II region (star).
The two folding domains observed in the C-terminal  domain of  SARS-CoV E are remi‐
niscent of the two separate domains reported for the amyloid peptide [137], where frag‐
ment 34–42 has limited solubility and adopts antiparallel β-sheet structure, and fragment
26–33  is  more  soluble  in  water,  and has  a  disordered conformation.  Thus,  we tested  if
peptide  (36-76)  can  form  amyloid-like  fibrils.  The  aggregate  obtained  after  drying  this
peptide from acetonitrile showed intense X-ray reflections at ~4.8 Å and ~10.8 Å (Fig. 6f),
which correspond to the distances between hydrogen bonded peptide backbones and β–
pleated sheets, respectively, characteristically found in Alzheimer disease amyloid plaque
cores [137]. This peptide was monomeric in SDS. Based on the above results, a topologi‐
cal model for SARS-CoV E can be proposed, with one α-helical TM domain and a C-ter‐
minal  β-hairpin  (Fig.  6g).  We  have  reported  previously  that  SARS-CoV  E  secondary
structure  in  lipid  bilayers  is  predominantly  α-helical  [67],  in  contrast  with  the  results
shown in Fig.  6e.  However,  we have found that the secondary structure of E protein is
strongly dependent on the reconstitution conditions. In our previous report [67], the pro‐
tein was presolubilized in hexafluoroisopropanol,  an α-helix inducer,  whereas in Fig.  6e
pre-solubilization was done in methanol.  Thus,  the β-hairpin prediction for the residues
around  the  highly  conserved  residue  P54,  may  be  correct  only  in  certain  experimental
conditions.  The dual  conformation,  α-helical  and β-hairpin,  conformation proposed here
is  reminiscent  of  the  proposed  dual  topology  of  a  similar  β-hairpin  with  central  con‐
served Pro residue found in stomatin. In that case, secondary structure changed to α-he‐
lix when Pro was mutated to Ser [138].
Examination of the peptide (36-76) precipitate by electron microscopy (Fig. 7A) revealed a
protofibrillar morphology [139-141]. These structures were not observed in the control speci‐
men prepared in the absence of peptide (Fig. 7B). The fibrils form an ordered mesh structure
characterized by straight sections intervened by bends. The fibril width was 7, 8 and 10 nm,
consistent with reports of other filaments derived from β-sheet structures [141-143]. The
length of the straight sections was rather homogenous, with most measurements falling be‐
tween 20-40 nm and with an average value of 32 nm.
The formation of fibrils is anticipated by the residue composition in the region around the
conserved proline (P54). For example, from the 17 residues in the stretch I46 to V62, 9 resi‐
dues are either V, I or Y. Amino acids with β-branched side chains, e.g. valine and isoleu‐
cine, or bulky residues, have been shown previously to disfavor α-helical conformation, and
to pack efficiently along the surface of a β-sheet [144, 145]. Accordingly, a series of hexapep‐
tides containing similar motifs (e.g., VxVx) have been shown to be good amyloid-forming
peptides [146]. We speculate that changing some of these residues to non-branched, for ex‐
ample from V to L, would abolish the ability of SARS-CoV E to form fibers, and possibly
Respiratory Disease and Infection - A New Insight62
attenuate the observed cytopathological effects of SARS-CoV E in cells. Indeed, a similar
strategy led to disruption of Golgi targeting in SARS-CoV E [106].
Figure 7. Electron microscopy and image processing; (A) Micrograph of a negatively stained sample of peptide
36-76 dissolved in acetonitrile. The ordered mesh is formed by 7-10 nm wide fibrils with 20-40 nm long straight sec‐
tions. Globular structures of 10-50 nm diameter are also present; (B) Control specimen without peptide showing simi‐
lar globular structures; (C, D) Magnified views of fibril branching points; (E) Two thin fibrils merging into a thicker one;
(F) Class average of the 8 nm fibril; (G) Histogram of the lengths of the fibril straight sections. (H) Intensity profile
along the x-axis of panel (F). The width of the peak above background level indicates filament thickness. The scale bar
is shown in each panel.




In addition, a sequence of ordered fragments (α-helices or strands) flanking a disordered or
turn loop, with Pro at its center, has been described for several fusion peptides, e.g., in EnvA
of the Avian sarcoma/leukosis virus subtype A (ASLV-A) [147], Ebola virus GP [148] and
mouse or macaque fertilin α (ADAM 1) [149], which suggests that this part of SARS-CoV E
is analogous to an internal fusion peptide. This motif has also been observed in a cis-proline
turn [150] linking two β-hairpin strands in the structure of an HIV-1IIIB V3 peptide. It was
found by mutagenesis of the fusion peptide of Env in ASLV-A, that proline, or a residue of
similar intermediate hydrophobicity, are part of an accessible loop and was needed for ini‐
tial interactions of fusion peptides with target membranes.
Amyloid fiber formation has been reported for fragments of many non pathogenic proteins
[151], and they have been found in a variety of proteins which are not associated with dis‐
ease [152, 153]. Therefore, this finding may not have relevance for the toxicity of the virus.
Nevertheless, this possibility cannot be discarded in view of other roles of similar semen-
derived fibers in HIV viral entry which dramatically enhance HIV infection [154]. A more
likely possibility, however, is that this conformational plasticity is needed during membrane
fusion; a transition form a α-helical conformation to an antiparallel β-structure, with Pro as a
hinge, could drive membrane fusion by pulling the two membranes in close apposition.
NMR studies: towards the high-resolution structure of SARS-CoV E. Full-length SARS-
CoV E protein shows a high tendency to aggregate when solubilized in detergents, making
it difficult to find a suitable condition for structural determination. While the TM region
could be studied in DPC [25], 2D-HSQC spectra of full-length SARS-CoV E protein show
poor quality in DPC-solubilized samples, even when SDS is included to improve spectral
quality (Fig. 8A). Some degree of improvement can be observed with a truncated version of
SARS-CoV E, which is lacking ~10 amino acids at both termini (Fig. 8B). We have also ob‐
tained a good, well-dispersed spectrum for this construct in SDS (Fig. 8C), allowing us to
begin the structural determination of the extramembrane regions of SARS-CoV E.
Figure 8. TROSY-HSQC of SARS-CoV E protein in various detergent micelles. (A) full-length SARS-CoV E in a mix‐
ture of DPC and SDS, (B) truncated SARS-CoV E in DPC and (C) in SDS.
Respiratory Disease and Infection - A New Insight64
3. Conclusion
Viroporins constitute important components of viruses, and we are just beginning to un‐
derstand what  is  their  biological  role  during the viral  life  cycle.  One of  the main prob‐
lems in their  in  vitro  structural  and functional  study is  high hydrophobicity  and strong
tendency to aggregate. This may reflect their likely multifunctional role in the cell, inter‐
acting with several viral and host partners. This multifunctionality seems dictated by ge‐
netic minimalism observed in viruses, in turn forced by the need to rapidly produce new
progeny inside an alien environment.  Viroporins such as those presented here,  SH pro‐
tein and CoV E proteins, form complexes that are still not well characterized that are crit‐
ical  for  viral  eggress.  In  this  context,  the  biological  function  of  channel  activity  is  still
unknown.  More data  is  becoming available  with more purified proteins,  and inevitably
extrapolations  will  have  to  be  made  from  easier  to  handle  proteins.  For  example,  we
could obtain a reasonably detailed SH protein NMR spectrum in detergents,  but that  is
still not possible for E proteins. Even when structural data can be obtained, efforts will be
directed towards environments that best mimic the conditions of natural lipid bilayers, as
protein conformation is  likely to change.  With multidisciplinary action,  the key roles  of
viroporins will be elucidated in the near future.
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